US Patent 10294305 Method for treating a GD2 positive cancer
Patent 10294305 was granted and assigned to APEIRON Biologics on May, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 18, 2014
0
Date of Patent
May 21, 2019
0
Patent Applicant
Patent Application Number
14182776
0
Patent Citations Received
•••
Patent Inventor Names
Ruth Ladenstein
0
Hans Loibner
0
Isabel Klier
0
Oliver Mutschlechner
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10294305 Method for treating a GD2 positive cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
